KINDERHOOK, N.Y.--(BUSINESS WIRE)--American Bio Medica Corporation (NASDAQ:ABMC) announced today that it received a letter, dated October 22, 2008, from the Nasdaq Stock Market (NASDAQ) advising the Company that, because of the extraordinary market conditions, effective October 16, 2008, NASDAQ has suspended enforcement of the bid price and market value requirements through January 16, 2009. As a result of this suspension, ABMC will now have until February 10, 2009 to regain compliance.
